Corvus Pharmaceuticals, Inc. - 10-Q Filing
Corvus Pharmaceuticals reports third quarter 2026 financial results including equity method investment in Angel Pharmaceuticals Ltd.
Tickers: $CRVS
More Regulatory news
- CENTRUS ENERGY CORP - 8-K Filing
- SAGA COMMUNICATIONS INC - 8-K Filing
- NextBoat Inc. - 8-K Filing
- CIVISTA BANCSHARES, INC. - 8-K Filing
- RF Acquisition Corp II - 10-Q Filing
- ORASURE TECHNOLOGIES INC - 10-Q Filing
- Rocket Companies, Inc. - 8-K Filing
- Applied Aerospace & Defense, Inc. - 10-Q Filing
- Palomar Holdings, Inc. - 8-K Filing
- UNITED GUARDIAN INC - 10-Q Filing